The ROE as of November 2024 (TTM) for Decibel Therapeutics, Inc. (DBTX) is -56.38%

According to Decibel Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -56.38%. This represents a change of 153.13% compared to the average of -22.28% of the last 4 quarters.

Decibel Therapeutics, Inc. (DBTX) Historical ROE (quarterly & annually)

How has DBTX ROE performed in the past?

The mean historical ROE of Decibel Therapeutics, Inc. over the last ten years is -82.76%. The current -56.38% ROE has changed -31.87% with respect to the historical average. Over the past ten years (40 quarters), DBTX's ROE was at its highest in in the September 2020 quarter at 71.15%. The ROE was at its lowest in in the December 2019 quarter at -39.24%.

Decibel Therapeutics, Inc. (DBTX) ROE by Quarter and Year

Discovering the peaks and valleys of Decibel Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Decibel Therapeutics, Inc. (DBTX) Average ROE

How has DBTX ROE performed in the past?

The current ROE of Decibel Therapeutics, Inc. (DBTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Decibel Therapeutics, Inc. (DBTX) ROE vs. Peers

How is DBTX’s ROE compared to its peers?

Decibel Therapeutics, Inc.’s ROE is greater than Werewolf Therapeutics, Inc. (-58.83%), greater than Edgewise Therapeutics, Inc. (-26.83%), greater than Celcuity Inc. (-62.66%), greater than C4 Therapeutics, Inc. (-42.45%), greater than Aerovate Therapeutics, Inc. (-90.19%), greater than Adagene Inc. (-50.10%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.95%), greater than Rezolute, Inc. (-69.83%), greater than AN2 Therapeutics, Inc. (-57.63%), greater than Ikena Oncology, Inc. (-39.59%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), greater than HCW Biologics Inc. (-2516.87%), greater than Molecular Partners AG (-39.16%),

Build a custom stock screener for Decibel Therapeutics, Inc. (DBTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Decibel Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Decibel Therapeutics, Inc. (DBTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Decibel Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.